Introduction {#sec1-1}
============

The development of gastric cancer in the excluded stomach after Roux-en-Y gastric bypass (RYGB) is a rare event, with few reports in the literature \[[@ref1]\]. Examination of the excluded stomach via endoscopy is challenging, ultimately requiring most diagnoses to be made through surgery. We describe a novel, minimally invasive method of passing a pediatric gastroscope through a gastrostomy tube tract to diagnose malignancy in the excluded stomach. To our knowledge, this is the first report of such a case.

Case report {#sec1-2}
===========

A 74-year-old female who had undergone RYGB in 1975, with lung cancer in remission and vaginal cancer complicated by rectovaginal fistula requiring colostomy diversion, presented with one month of early satiety, 40-pound weight loss, and left upper quadrant abdominal pain. Her physical exam was notable for fullness and tenderness to palpation of the abdominal left upper quadrant. Laboratory testing was notable for a normocytic anemia with hemoglobin of 8.4 g/dL and normal iron studies. Her white blood cell count, liver function tests, and lipase were within normal limits. Abdominal computed tomography (CT) revealed severe dilation of the stomach, with thickening of the pylorus and duodenal bulb consistent with gastric outlet obstruction of the excluded stomach ([Fig. 1](#F1){ref-type="fig"}). Per-oral single-balloon enteroscopy was performed and revealed a normal gastric pouch and gastrojejunal anastomosis, but was unable to reach the excluded stomach because of sharp angulations of the small bowel, probably due to abdominal adhesions.

![Coronal computed tomography image revealing gastric outlet obstruction of the excluded stomach. Arrow reveals thickening of the gastric wall](AnnGastroenterol-30-367-g001){#F1}

The patient was evaluated by the surgical service, who deemed her a poor surgical candidate for laparoscopic exploration. An ultrasound-guided 12-French (Fr) gastrostomy tube was placed percutaneously by interventional radiology into the excluded stomach for decompression of the gastric outlet obstruction of the excluded stomach. In subsequent months, upsizing of the gastrostomy tube tract was performed until a 24-Fr tube was in place. She then underwent endoscopic evaluation under moderate sedation using a pediatric gastroscope (EVIS EXERA III GIF-XP190N gastroscope) with an outer diameter of 5.4 mm. For this procedure, carbon dioxide was used for insufflation but no trocar was used. The patient's existing 24-Fr gastrostomy tube was deflated and easily removed through the tract. A guidewire was coiled into the excluded stomach under endoscopic guidance. The pediatric gastroscope was advanced alongside the guidewire into the excluded stomach. A large, friable, ulcerated mass ([Fig. 2](#F2){ref-type="fig"}) was identified and multiple biopsies were taken, later identified as poorly differentiated adenocarcinoma with signet ring and mucinous features consistent with primary gastrointestinal malignancy. After removal of the gastroscope, a new 24-Fr gastrostomy tube was advanced without difficulty into the excluded tract and its position was confirmed via injection of contrast through the tube. She was deemed a poor surgical and chemotherapy candidate, eventually passing away in a hospice.

![Endoscopic view of a large friable, ulcerated mass within the excluded stomach. A later biopsy proved it to be a poorly differentiated gastric adenocarcinoma](AnnGastroenterol-30-367-g002){#F2}

Discussion {#sec1-3}
==========

Gastric cancer in the excluded stomach following RYGB is rare, with an estimated incidence of 0.03% \[[@ref2]\]. The case presented in the current report represents the longest interval between RYGB and development of gastric cancer in the excluded stomach, at 41 years. Currently there is no clear explanation behind the development of cancer in the excluded stomach after bariatric surgery. Some prominent hypotheses include bile reflux, gastric stasis, chronic reflux, dysplasia due to excess intraluminal pressure and ischemia, and metaplasia due to chronic inflammation \[[@ref3]\]. Diagnosis can be challenging, as symptoms are nonspecific and often go unrecognized, resulting in a late presentation. The most frequently reported symptoms include dysphagia and food intolerance, nausea and vomiting, abdominal or epigastric pain, and weight loss \[[@ref4]\].

Post-RYGB patients with symptoms that raise concern for gastric malignancy require assessment of the excluded stomach, as non-adenocarcinoma pathologies, such as linitis plastica and gastrointestinal stromal tumors, have been reported \[[@ref5],[@ref6]\]. Unfortunately, accessing the excluded stomach is challenging because of the altered anatomy following RYGB. Several methods have been developed for both diagnostic and therapeutic interventions, each with limitations ([Table 1](#T1){ref-type="table"}). Retrograde endoscopic intubation of the excluded stomach via a pediatric colonoscope can be successful in 65% of patients \[[@ref7]\]. However, this method is limited when a longer Roux limb is created. Balloon-assisted enteroscopy has emerged as a useful method of accessing the excluded stomach. Though the total length of the afferent and efferent limbs is less of a concern, major adhesions and technical experience can limit its success. Laparoscopic transgastric endoscopy has also been used as an approach to access the excluded stomach safely, though this can also be more complex in the setting of adhesions \[[@ref8]\].

###### 

A list of methods that can be used to access the excluded stomach and common limitations that may discourage their use
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To circumvent some of the challenges posed by the above approaches, a gastrostomy tube can be placed percutaneously by interventional radiology in the excluded stomach, under fluoroscopic, endoscopic ultrasound (EUS), or CT guidance. More recently, an EUS-guided approach by interventional gastroenterologists can be employed \[[@ref9]\]. CT- or EUS-guided fine-needle aspiration can be used if the mass in the excluded stomach is seen with these imaging techniques; however, this is often not the case. As in this patient, a percutaneously placed gastrostomy tube can be upsized to 24-Fr to facilitate endoscopy of the excluded stomach; the gastrostomy tract is likely to be mature and stable for percutaneous endoscopy after 3-4 weeks. The gastrostomy tube should be at least 20-Fr or 22-Fr to allow passage of the pediatric gastroscope directly into the stomach. If a smaller tube is used, a controlled radial expansion dilating balloon can be used to dilate the gastrostomy tube tract to 6-8 mm, allowing easy passage of the gastroscope. A guidewire can be placed through the tube into the stomach to maintain access, but this is often not necessary.

This case highlights the importance of endoscopic evaluation of the excluded stomach in RYGB patients with features that raise concern for gastric malignancy, such as unexpected delayed weight loss, worsening anemia, and gastric outlet obstruction. In these RYGB patients with worrisome symptoms, we demonstrate the feasibility of a minimally invasive percutaneous endoscopic approach, using a gastrostomy tube for endoscopic access to the excluded stomach, when balloon-assisted enteroscopy is not technically feasible or is unavailable.
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